Skip to Main Content

Author Details

Timo Wolf
Goethe University Frankfurt, University Hospital
2003
83
25
PMIDPaper TitleJournal TitlePublished Year
36581734Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial.Nat Cancer2023
37957379Dynamics and durability of HIV-1 neutralization are determined by viral replication.Nat Med2023
37454889Time discrepancy for tuberculosis-negative microscopy and culture - the diagnostic gap remains: systematic analysis from a large tertiary care tuberculosis-clinic, Germany 2013-2017.Int J Infect Dis2023
37273167Tecovirimat for the treatment of severe Mpox in Germany.Infection2023
34318871Leveraging a Preexisting Global Infectious Disease Network for Local Decision Making During a Pandemic.Clin Infect Dis2022
35834885Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.EBioMedicine2022
35667065Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.Ann Intern Med2022
34920374Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design.J Clin Virol2022
34788633High overall mortality of Mycobacterium genavense infections and impact of antimycobacterial therapy: Systematic review and individual patient data meta-analysis.J Infect2022
33128369Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.J Infect Dis2021
33865770Myocardial Fibrosis and Inflammation by CMR Predict Cardiovascular Outcome in People Living With HIV.JACC Cardiovasc Imaging2021
34407479Lung Ultrasound Effectively Detects HIV-Associated Interstitial Pulmonary Disease.Int J Infect Dis2021
34578275Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q.Viruses2021
34393518Evaluation of Platelet Activation by HIV Protease Inhibitors - The HIV-PLA II Study.HIV AIDS (Auckl)2021
34592994Powered air-purifying respirators used during the SARS-CoV-2 pandemic significantly reduce speech perception.J Occup Med Toxicol2021
34223909Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro.J Infect Dis2021
34242683Risk factors for IRIS in HIV-associated Pneumocystis-pneumonia following ART initiation.J Infect2021
33959944Characteristics and outcome of human immunodeficiency virus (HIV)-associated primary effusion lymphoma as observed in the German HIV-related lymphoma cohort study.Br J Haematol2021
34255788Disseminated disease due to non-tuberculous mycobacteria in HIV positive patients: A retrospective case control study.PLoS One2021
33047484Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors.HIV Med2021
32408155Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.Mult Scler Relat Disord2020
32069388Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China.N Engl J Med2020
32946786Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.Cell2020
32938741Antimicrobial Susceptibility and Phylogenetic Relations in a German Cohort Infected with Mycobacterium abscessus.J Clin Microbiol2020
32219400Fifty years of imported Lassa fever: a systematic review of primary and secondary cases.J Travel Med2020
32147539Comparative analysis of phenotypic and genotypic antibiotic susceptibility patterns in Mycobacterium avium complex.Int J Infect Dis2020
32463974Epitopes of Naturally Acquired and Vaccine-Induced Anti-Ebola Virus Glycoprotein Antibodies in Single Amino Acid Resolution.Biotechnol J2020
31093923Species distribution and clinical features of infection and colonisation with non-tuberculous mycobacteria in a tertiary care centre, central Germany, 2006-2016.Infection2019
31686639Sex and Gender Differences in Rilpivirine based ART - Data from the HIVCENTER Frankfurt.Curr HIV Res2019
31822328Two cases of airport-associated falciparum malaria in Frankfurt am Main, Germany, October 2019.Euro Surveill2019
31591605Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV.Nat Med2019
30926957New filovirus disease classification and nomenclature.Nat Rev Microbiol2019
31071480Clinical characteristics in a sentinel case as well as in a cluster of tularemia patients associated with grape harvest.Int J Infect Dis2019
29262692Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.AIDS Res Hum Retroviruses2018
29971922Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years.HIV Med2018
29439188Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study.Haematologica2018
29742276HLA-B57.01 shields people living with HIV for significantly better periodontal health.J Periodontol2018
29460758New Lineage of Lassa Virus, Togo, 2016.Emerg Infect Dis2018
29017278Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.Clin Infect Dis2017
28253516HIV-Associated Malignant Lymphoma.Oncol Res Treat2017
29019307Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016.Euro Surveill2017
25947417Rapid regression of Kaposi's sarcoma of the hard palate under therapy with boosted elvitegravir-containing fixdose antiretroviral combination therapy.Infection2016
26429890Efficacy of raltegravir-containing regimens in antiretroviral-naïve and -experienced individuals in routine clinical practice.Int J STD AIDS2016
26605513CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma.AIDS2016
27795234Complete Genome Sequence of an Ebola Virus Isolate Imported from Sierra Leone to Germany Determined by Circle Sequencing.Genome Announc2016
27660771Genome Sequence of Lassa Virus Isolated from the First Domestically Acquired Case in Germany.Genome Announc2016
27469377HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy.Med Microbiol Immunol2016
26886522Clinical Management of Ebola Virus Disease in the United States and Europe.N Engl J Med2016
26766162Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.Vox Sang2016
25403997Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort.Br J Haematol2015
  • 1 - 50 of 83

Recommended Authors

Padua University Hospital
Career Start Year 2016
Number of shared co-authors 0
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 2
University of Kansas Medical Center
Career Start Year 2006
Number of shared co-authors 0
University of Minnesota
Career Start Year 2003
Number of shared co-authors 4
Hospital Clinico San Carlos
Career Start Year 2003
Number of shared co-authors 0
University of California san francisco
Career Start Year 2002
Number of shared co-authors 1
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 6
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 0
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Career Start Year 1999
Number of shared co-authors 3
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 3
&quotMagna Graecia&quot University
Career Start Year 1998
Number of shared co-authors 3
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 2
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 5
Hospital Universitario de Guadalajara
Career Start Year 1991
Number of shared co-authors 1
Instituto de Investigacion Sanitaria Gregorio Maranon (IiSGM)
Career Start Year 1991
Number of shared co-authors 0
Hospital Clinico San Carlos-IdiSSC, Universidad Complutense
Career Start Year 1988
Number of shared co-authors 2
University of Massachusetts Medical School-Baystate
Career Start Year 1988
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 8
University of Cincinnati
Career Start Year 1988
Number of shared co-authors 2
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 1
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 1
VA Medical Center
Career Start Year 1986
Number of shared co-authors 2
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 2
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 3
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 5
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 0
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 3
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 2
Wistar Institute
Career Start Year 1958
Number of shared co-authors 0

Collaborators

Institute of Virology, Philipps University Marburg
Co-authored papers 10
Goethe University, University Hospital Frankfurt
Co-authored papers 7
Emory University School of Medicine
Co-authored papers 4
Co-authored papers 4
Hospital Chemnitz
Co-authored papers 3
Emory University School of Medicine
Co-authored papers 3
University of Nebraska Medical Center
Co-authored papers 3
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Co-authored papers 3
Emory University School of Medicine
Co-authored papers 3
Emory University School of Medicine
Co-authored papers 3
University of Washington
Co-authored papers 2
Italian Ministry of Health
Co-authored papers 2
US Centers for Disease Control and Prevention
Co-authored papers 2
Royal Free NHS Foundation Trust
Co-authored papers 2
University Medical Center Utrecht
Co-authored papers 2
La Paz University Hospital
Co-authored papers 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 2
Begin Military Teaching Hospital
Co-authored papers 2
University Hospital of Geneva
Co-authored papers 2
Oslo University Hospital
Co-authored papers 2
Ministry of Health
Co-authored papers 1
Christchurch Hospital
Co-authored papers 1
University of Pretoria
Co-authored papers 1
The University of North Carolina School of Medicine
Co-authored papers 1
ELWA Hospital
Co-authored papers 1
Infectious Disease Clinical Research Program, Uniformed Services University
Co-authored papers 1
Uganda Virus Research Institute, Ministry of Health
Co-authored papers 1
University of North Carolina School of Medicine
Co-authored papers 1
Sierra Leone Ministry of Health and Sanitation.
Co-authored papers 1
Adachi Mental Clinic
Co-authored papers 1